These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7339639)

  • 1. Theoretical and practical importance of plasma levels of haloperidol. Correlations with clinical and computerized EEG data.
    De Buck RP; Zelaschi N; Gilles C; Durdu J; Brauman H
    Prog Neuropsychopharmacol; 1981; 5(5-6):499-502. PubMed ID: 7339639
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of haloperidol on the EEG spectrum.
    Wieneke GH; Verhoeven WM; Westenberg HG; de Wilde H; Lopes da Silva FH; van Praag M; Storm van Leeuwen W
    Psychopharmacology (Berl); 1981; 74(1):33-4. PubMed ID: 6791200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood levels of haloperidol and clinical outcome in schizophrenia.
    Doddi S; Rifkin A; Karajgi B; Cooper T; Borenstein M
    J Clin Psychopharmacol; 1994 Jun; 14(3):187-95. PubMed ID: 8027415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
    Smith RC; Vroulis G; Shvartsburd A; Allen R; Lewis N; Schoolar JC; Chojnacki M; Johnson R
    Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital computer analyzed sleep and resting EEG during haloperidol treatment.
    Itil TM; Gannon P; Hsu W; Klingenberg H
    Am J Psychiatry; 1970 Oct; 127(4):462-71. PubMed ID: 4318894
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced haloperidol/haloperidol ratios after oral haloperidol and decanoate administration in schizophrenics.
    Chang WH; Lin SK; Juang DJ; Chen LC; Yang CH; Hu WH; Chien CP; Lam YF; Jann MW
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jan; 17(1):105-12. PubMed ID: 8416597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predicting the effects of haloperidol on schizophrenics by quantitative pharmaco-EEG].
    Zhang XL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):300-2, 318. PubMed ID: 1291253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of phenothiazine and nonphenothiazine neuroleptics according to psychopathology, side effects and computerized EEG.
    Itil TM; Patterson CD; Keskiner A; Holden JM
    Adv Biochem Psychopharmacol; 1974; 9(0):499-509. PubMed ID: 4599437
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of the therapeutic effects between haloperidol and insulin coma in schizophrenia and optimal blood levels of haloperidol].
    Shu L
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1987 Feb; 20(1):43-8. PubMed ID: 3304870
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum haloperidol levels in Gilles de la Tourette syndrome.
    Singer HS; Rabins P; Tune LE; Coyle JT
    Biol Psychiatry; 1981 Jan; 16(1):79-84. PubMed ID: 6939449
    [No Abstract]   [Full Text] [Related]  

  • 11. Reduced haloperidol plasma concentration and clinical response in acute exacerbations of schizophrenia.
    Kelly MW; Perry PJ; Coryell WH; Miller DD; Arndt SV
    Psychopharmacology (Berl); 1990; 102(4):514-20. PubMed ID: 2096408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma haloperidol levels drawn at neuroleptic threshold doses: a pilot study.
    McEvoy JP; Stiller RL; Farr R
    J Clin Psychopharmacol; 1986 Jun; 6(3):133-8. PubMed ID: 3711363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dynamic changes in the EEG after oral administration of haloperidol in 4 normal individuals].
    He Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):291-3, 319. PubMed ID: 3234161
    [No Abstract]   [Full Text] [Related]  

  • 14. [Haloperidol. Plasma monitoring and hormonal effects of treatment].
    Goyot C; Debray Q; Dugas M; Guay C; Giraud J; Grenier J
    Pathol Biol (Paris); 1985 Dec; 33(10):999-1004. PubMed ID: 2937009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose and blood levels of haloperidol in treatment of mania.
    Rifkin A; Karajgi B; Doddi S; Cooper T
    Psychopharmacol Bull; 1990; 26(1):144-6. PubMed ID: 2371369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haloperidol plasma levels and dose optimization.
    Coryell W; Miller DD; Perry PJ
    Am J Psychiatry; 1998 Jan; 155(1):48-53. PubMed ID: 9433338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-dependent reduced haloperidol/haloperidol ratios in schizophrenic patients.
    Chang WH; Hwu HG; Lane HY; Lin SK; Chen TY; Chen H; Wei HL; Lin WL; Lin HN
    Psychiatry Res; 1991 Sep; 38(3):215-25. PubMed ID: 1754634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of parenteral administration of haloperidol in man. II. Male chronic schizophrenics: quantitative EEG findings.
    Pfeiffer CC; Goldstein L; Sugerman AA
    J Clin Pharmacol J New Drugs; 1968; 8(2):89-94. PubMed ID: 5240367
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of dopamine receptor blocking assay with plasma drug levels of haloperidol in schizophrenic patients.
    Kurland AA; Nagaraju A; Hanlon TE; Wilkinson EH; Ng KT
    J Clin Pharmacol; 1981 Jan; 21(1):42-7. PubMed ID: 7217342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EEG abnormalities associated with antipsychotics: a comparison of quetiapine, olanzapine, haloperidol and healthy subjects.
    Amann BL; Pogarell O; Mergl R; Juckel G; Grunze H; Mulert C; Hegerl U
    Hum Psychopharmacol; 2003 Dec; 18(8):641-6. PubMed ID: 14696024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.